[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Flu RNA Vaccines Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

February 2023 | 100 pages | ID: GD12DF3D157BEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The major advantage of Flu RNA Vaccines is that scientist need not to use the live cells for the vaccine preparation as such the RNA can be produced in the laboratory from a DNA template using readily available materials which can be a easy and fast weapon to fight against the new outbreaks and the existing infectious diseases.

According to our (Global Info Research) latest study, the global Flu RNA Vaccines market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Flu RNA Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Flu RNA Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Flu RNA Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Flu RNA Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Flu RNA Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Flu RNA Vaccines

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Flu RNA Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur Inc., AstraZeneca, CSL Ltd., Abbott and GlaxoSmithKline Plc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Flu RNA Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • Non-Replicating mRNA
  • In Vivo Self-Replicating mRNA
  • In Vitro Dendritic Cell Non-Replicating mRNA Vaccine
  • Others
Market segment by Application
  • Hospitals
  • Vaccination Center
  • Specialized Clinics
  • Hospital Pharmacy
  • Others
Major players covered
  • Sanofi Pasteur Inc.
  • AstraZeneca
  • CSL Ltd.
  • Abbott
  • GlaxoSmithKline Plc.
  • Serum Institute of India Pvt. Ltd.
  • Pfizer
  • BioNTech
  • F.Hoffman La Roche Ltd
  • Novartis
  • Sinnovac Biotech Ltd
  • Moderna Therapeutics
  • CureVac
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Flu RNA Vaccines product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Flu RNA Vaccines, with price, sales, revenue and global market share of Flu RNA Vaccines from 2018 to 2023.

Chapter 3, the Flu RNA Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Flu RNA Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Flu RNA Vaccines market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Flu RNA Vaccines.

Chapter 14 and 15, to describe Flu RNA Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Flu RNA Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Flu RNA Vaccines Consumption Value by Type: 2018 Versus 2022 Versus 2029
  1.3.2 Non-Replicating mRNA
  1.3.3 In Vivo Self-Replicating mRNA
  1.3.4 In Vitro Dendritic Cell Non-Replicating mRNA Vaccine
  1.3.5 Others
1.4 Market Analysis by Application
  1.4.1 Overview: Global Flu RNA Vaccines Consumption Value by Application: 2018 Versus 2022 Versus 2029
  1.4.2 Hospitals
  1.4.3 Vaccination Center
  1.4.4 Specialized Clinics
  1.4.5 Hospital Pharmacy
  1.4.6 Others
1.5 Global Flu RNA Vaccines Market Size & Forecast
  1.5.1 Global Flu RNA Vaccines Consumption Value (2018 & 2022 & 2029)
  1.5.2 Global Flu RNA Vaccines Sales Quantity (2018-2029)
  1.5.3 Global Flu RNA Vaccines Average Price (2018-2029)

2 MANUFACTURERS PROFILES

2.1 Sanofi Pasteur Inc.
  2.1.1 Sanofi Pasteur Inc. Details
  2.1.2 Sanofi Pasteur Inc. Major Business
  2.1.3 Sanofi Pasteur Inc. Flu RNA Vaccines Product and Services
  2.1.4 Sanofi Pasteur Inc. Flu RNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.1.5 Sanofi Pasteur Inc. Recent Developments/Updates
2.2 AstraZeneca
  2.2.1 AstraZeneca Details
  2.2.2 AstraZeneca Major Business
  2.2.3 AstraZeneca Flu RNA Vaccines Product and Services
  2.2.4 AstraZeneca Flu RNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.2.5 AstraZeneca Recent Developments/Updates
2.3 CSL Ltd.
  2.3.1 CSL Ltd. Details
  2.3.2 CSL Ltd. Major Business
  2.3.3 CSL Ltd. Flu RNA Vaccines Product and Services
  2.3.4 CSL Ltd. Flu RNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.3.5 CSL Ltd. Recent Developments/Updates
2.4 Abbott
  2.4.1 Abbott Details
  2.4.2 Abbott Major Business
  2.4.3 Abbott Flu RNA Vaccines Product and Services
  2.4.4 Abbott Flu RNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.4.5 Abbott Recent Developments/Updates
2.5 GlaxoSmithKline Plc.
  2.5.1 GlaxoSmithKline Plc. Details
  2.5.2 GlaxoSmithKline Plc. Major Business
  2.5.3 GlaxoSmithKline Plc. Flu RNA Vaccines Product and Services
  2.5.4 GlaxoSmithKline Plc. Flu RNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.5.5 GlaxoSmithKline Plc. Recent Developments/Updates
2.6 Serum Institute of India Pvt. Ltd.
  2.6.1 Serum Institute of India Pvt. Ltd. Details
  2.6.2 Serum Institute of India Pvt. Ltd. Major Business
  2.6.3 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Product and Services
  2.6.4 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.6.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
2.7 Pfizer
  2.7.1 Pfizer Details
  2.7.2 Pfizer Major Business
  2.7.3 Pfizer Flu RNA Vaccines Product and Services
  2.7.4 Pfizer Flu RNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.7.5 Pfizer Recent Developments/Updates
2.8 BioNTech
  2.8.1 BioNTech Details
  2.8.2 BioNTech Major Business
  2.8.3 BioNTech Flu RNA Vaccines Product and Services
  2.8.4 BioNTech Flu RNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.8.5 BioNTech Recent Developments/Updates
2.9 F.Hoffman La Roche Ltd
  2.9.1 F.Hoffman La Roche Ltd Details
  2.9.2 F.Hoffman La Roche Ltd Major Business
  2.9.3 F.Hoffman La Roche Ltd Flu RNA Vaccines Product and Services
  2.9.4 F.Hoffman La Roche Ltd Flu RNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.9.5 F.Hoffman La Roche Ltd Recent Developments/Updates
2.10 Novartis
  2.10.1 Novartis Details
  2.10.2 Novartis Major Business
  2.10.3 Novartis Flu RNA Vaccines Product and Services
  2.10.4 Novartis Flu RNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.10.5 Novartis Recent Developments/Updates
2.11 Sinnovac Biotech Ltd
  2.11.1 Sinnovac Biotech Ltd Details
  2.11.2 Sinnovac Biotech Ltd Major Business
  2.11.3 Sinnovac Biotech Ltd Flu RNA Vaccines Product and Services
  2.11.4 Sinnovac Biotech Ltd Flu RNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.11.5 Sinnovac Biotech Ltd Recent Developments/Updates
2.12 Moderna Therapeutics
  2.12.1 Moderna Therapeutics Details
  2.12.2 Moderna Therapeutics Major Business
  2.12.3 Moderna Therapeutics Flu RNA Vaccines Product and Services
  2.12.4 Moderna Therapeutics Flu RNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.12.5 Moderna Therapeutics Recent Developments/Updates
2.13 CureVac
  2.13.1 CureVac Details
  2.13.2 CureVac Major Business
  2.13.3 CureVac Flu RNA Vaccines Product and Services
  2.13.4 CureVac Flu RNA Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.13.5 CureVac Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: FLU RNA VACCINES BY MANUFACTURER

3.1 Global Flu RNA Vaccines Sales Quantity by Manufacturer (2018-2023)
3.2 Global Flu RNA Vaccines Revenue by Manufacturer (2018-2023)
3.3 Global Flu RNA Vaccines Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
  3.4.1 Producer Shipments of Flu RNA Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
  3.4.2 Top 3 Flu RNA Vaccines Manufacturer Market Share in 2022
  3.4.2 Top 6 Flu RNA Vaccines Manufacturer Market Share in 2022
3.5 Flu RNA Vaccines Market: Overall Company Footprint Analysis
  3.5.1 Flu RNA Vaccines Market: Region Footprint
  3.5.2 Flu RNA Vaccines Market: Company Product Type Footprint
  3.5.3 Flu RNA Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Flu RNA Vaccines Market Size by Region
  4.1.1 Global Flu RNA Vaccines Sales Quantity by Region (2018-2029)
  4.1.2 Global Flu RNA Vaccines Consumption Value by Region (2018-2029)
  4.1.3 Global Flu RNA Vaccines Average Price by Region (2018-2029)
4.2 North America Flu RNA Vaccines Consumption Value (2018-2029)
4.3 Europe Flu RNA Vaccines Consumption Value (2018-2029)
4.4 Asia-Pacific Flu RNA Vaccines Consumption Value (2018-2029)
4.5 South America Flu RNA Vaccines Consumption Value (2018-2029)
4.6 Middle East and Africa Flu RNA Vaccines Consumption Value (2018-2029)

5 MARKET SEGMENT BY TYPE

5.1 Global Flu RNA Vaccines Sales Quantity by Type (2018-2029)
5.2 Global Flu RNA Vaccines Consumption Value by Type (2018-2029)
5.3 Global Flu RNA Vaccines Average Price by Type (2018-2029)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Flu RNA Vaccines Sales Quantity by Application (2018-2029)
6.2 Global Flu RNA Vaccines Consumption Value by Application (2018-2029)
6.3 Global Flu RNA Vaccines Average Price by Application (2018-2029)

7 NORTH AMERICA

7.1 North America Flu RNA Vaccines Sales Quantity by Type (2018-2029)
7.2 North America Flu RNA Vaccines Sales Quantity by Application (2018-2029)
7.3 North America Flu RNA Vaccines Market Size by Country
  7.3.1 North America Flu RNA Vaccines Sales Quantity by Country (2018-2029)
  7.3.2 North America Flu RNA Vaccines Consumption Value by Country (2018-2029)
  7.3.3 United States Market Size and Forecast (2018-2029)
  7.3.4 Canada Market Size and Forecast (2018-2029)
  7.3.5 Mexico Market Size and Forecast (2018-2029)

8 EUROPE

8.1 Europe Flu RNA Vaccines Sales Quantity by Type (2018-2029)
8.2 Europe Flu RNA Vaccines Sales Quantity by Application (2018-2029)
8.3 Europe Flu RNA Vaccines Market Size by Country
  8.3.1 Europe Flu RNA Vaccines Sales Quantity by Country (2018-2029)
  8.3.2 Europe Flu RNA Vaccines Consumption Value by Country (2018-2029)
  8.3.3 Germany Market Size and Forecast (2018-2029)
  8.3.4 France Market Size and Forecast (2018-2029)
  8.3.5 United Kingdom Market Size and Forecast (2018-2029)
  8.3.6 Russia Market Size and Forecast (2018-2029)
  8.3.7 Italy Market Size and Forecast (2018-2029)

9 ASIA-PACIFIC

9.1 Asia-Pacific Flu RNA Vaccines Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Flu RNA Vaccines Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Flu RNA Vaccines Market Size by Region
  9.3.1 Asia-Pacific Flu RNA Vaccines Sales Quantity by Region (2018-2029)
  9.3.2 Asia-Pacific Flu RNA Vaccines Consumption Value by Region (2018-2029)
  9.3.3 China Market Size and Forecast (2018-2029)
  9.3.4 Japan Market Size and Forecast (2018-2029)
  9.3.5 Korea Market Size and Forecast (2018-2029)
  9.3.6 India Market Size and Forecast (2018-2029)
  9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
  9.3.8 Australia Market Size and Forecast (2018-2029)

10 SOUTH AMERICA

10.1 South America Flu RNA Vaccines Sales Quantity by Type (2018-2029)
10.2 South America Flu RNA Vaccines Sales Quantity by Application (2018-2029)
10.3 South America Flu RNA Vaccines Market Size by Country
  10.3.1 South America Flu RNA Vaccines Sales Quantity by Country (2018-2029)
  10.3.2 South America Flu RNA Vaccines Consumption Value by Country (2018-2029)
  10.3.3 Brazil Market Size and Forecast (2018-2029)
  10.3.4 Argentina Market Size and Forecast (2018-2029)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Flu RNA Vaccines Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Flu RNA Vaccines Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Flu RNA Vaccines Market Size by Country
  11.3.1 Middle East & Africa Flu RNA Vaccines Sales Quantity by Country (2018-2029)
  11.3.2 Middle East & Africa Flu RNA Vaccines Consumption Value by Country (2018-2029)
  11.3.3 Turkey Market Size and Forecast (2018-2029)
  11.3.4 Egypt Market Size and Forecast (2018-2029)
  11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
  11.3.6 South Africa Market Size and Forecast (2018-2029)

12 MARKET DYNAMICS

12.1 Flu RNA Vaccines Market Drivers
12.2 Flu RNA Vaccines Market Restraints
12.3 Flu RNA Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
  12.5.1 Influence of COVID-19
  12.5.2 Influence of Russia-Ukraine War

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Flu RNA Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Flu RNA Vaccines
13.3 Flu RNA Vaccines Production Process
13.4 Flu RNA Vaccines Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Flu RNA Vaccines Typical Distributors
14.3 Flu RNA Vaccines Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Flu RNA Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Flu RNA Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Pasteur Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Pasteur Inc. Major Business
Table 5. Sanofi Pasteur Inc. Flu RNA Vaccines Product and Services
Table 6. Sanofi Pasteur Inc. Flu RNA Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Pasteur Inc. Recent Developments/Updates
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Major Business
Table 10. AstraZeneca Flu RNA Vaccines Product and Services
Table 11. AstraZeneca Flu RNA Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AstraZeneca Recent Developments/Updates
Table 13. CSL Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. CSL Ltd. Major Business
Table 15. CSL Ltd. Flu RNA Vaccines Product and Services
Table 16. CSL Ltd. Flu RNA Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. CSL Ltd. Recent Developments/Updates
Table 18. Abbott Basic Information, Manufacturing Base and Competitors
Table 19. Abbott Major Business
Table 20. Abbott Flu RNA Vaccines Product and Services
Table 21. Abbott Flu RNA Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Abbott Recent Developments/Updates
Table 23. GlaxoSmithKline Plc. Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Plc. Major Business
Table 25. GlaxoSmithKline Plc. Flu RNA Vaccines Product and Services
Table 26. GlaxoSmithKline Plc. Flu RNA Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. GlaxoSmithKline Plc. Recent Developments/Updates
Table 28. Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Serum Institute of India Pvt. Ltd. Major Business
Table 30. Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Product and Services
Table 31. Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Serum Institute of India Pvt. Ltd. Recent Developments/Updates
Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Major Business
Table 35. Pfizer Flu RNA Vaccines Product and Services
Table 36. Pfizer Flu RNA Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Pfizer Recent Developments/Updates
Table 38. BioNTech Basic Information, Manufacturing Base and Competitors
Table 39. BioNTech Major Business
Table 40. BioNTech Flu RNA Vaccines Product and Services
Table 41. BioNTech Flu RNA Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. BioNTech Recent Developments/Updates
Table 43. F.Hoffman La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 44. F.Hoffman La Roche Ltd Major Business
Table 45. F.Hoffman La Roche Ltd Flu RNA Vaccines Product and Services
Table 46. F.Hoffman La Roche Ltd Flu RNA Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. F.Hoffman La Roche Ltd Recent Developments/Updates
Table 48. Novartis Basic Information, Manufacturing Base and Competitors
Table 49. Novartis Major Business
Table 50. Novartis Flu RNA Vaccines Product and Services
Table 51. Novartis Flu RNA Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Novartis Recent Developments/Updates
Table 53. Sinnovac Biotech Ltd Basic Information, Manufacturing Base and Competitors
Table 54. Sinnovac Biotech Ltd Major Business
Table 55. Sinnovac Biotech Ltd Flu RNA Vaccines Product and Services
Table 56. Sinnovac Biotech Ltd Flu RNA Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Sinnovac Biotech Ltd Recent Developments/Updates
Table 58. Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 59. Moderna Therapeutics Major Business
Table 60. Moderna Therapeutics Flu RNA Vaccines Product and Services
Table 61. Moderna Therapeutics Flu RNA Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Moderna Therapeutics Recent Developments/Updates
Table 63. CureVac Basic Information, Manufacturing Base and Competitors
Table 64. CureVac Major Business
Table 65. CureVac Flu RNA Vaccines Product and Services
Table 66. CureVac Flu RNA Vaccines Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. CureVac Recent Developments/Updates
Table 68. Global Flu RNA Vaccines Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 69. Global Flu RNA Vaccines Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Flu RNA Vaccines Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 71. Market Position of Manufacturers in Flu RNA Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Flu RNA Vaccines Production Site of Key Manufacturer
Table 73. Flu RNA Vaccines Market: Company Product Type Footprint
Table 74. Flu RNA Vaccines Market: Company Product Application Footprint
Table 75. Flu RNA Vaccines New Market Entrants and Barriers to Market Entry
Table 76. Flu RNA Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Flu RNA Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 78. Global Flu RNA Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 79. Global Flu RNA Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Flu RNA Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Flu RNA Vaccines Average Price by Region (2018-2023) & (US$/Unit)
Table 82. Global Flu RNA Vaccines Average Price by Region (2024-2029) & (US$/Unit)
Table 83. Global Flu RNA Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Global Flu RNA Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Global Flu RNA Vaccines Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Flu RNA Vaccines Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Flu RNA Vaccines Average Price by Type (2018-2023) & (US$/Unit)
Table 88. Global Flu RNA Vaccines Average Price by Type (2024-2029) & (US$/Unit)
Table 89. Global Flu RNA Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Global Flu RNA Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Global Flu RNA Vaccines Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Flu RNA Vaccines Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Flu RNA Vaccines Average Price by Application (2018-2023) & (US$/Unit)
Table 94. Global Flu RNA Vaccines Average Price by Application (2024-2029) & (US$/Unit)
Table 95. North America Flu RNA Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 96. North America Flu RNA Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 97. North America Flu RNA Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 98. North America Flu RNA Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 99. North America Flu RNA Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 100. North America Flu RNA Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 101. North America Flu RNA Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Flu RNA Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Flu RNA Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Europe Flu RNA Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Europe Flu RNA Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 106. Europe Flu RNA Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 107. Europe Flu RNA Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 108. Europe Flu RNA Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 109. Europe Flu RNA Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Flu RNA Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Flu RNA Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 112. Asia-Pacific Flu RNA Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 113. Asia-Pacific Flu RNA Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 114. Asia-Pacific Flu RNA Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 115. Asia-Pacific Flu RNA Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 116. Asia-Pacific Flu RNA Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 117. Asia-Pacific Flu RNA Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Flu RNA Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Flu RNA Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 120. South America Flu RNA Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 121. South America Flu RNA Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 122. South America Flu RNA Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 123. South America Flu RNA Vaccines Sales Quantity by Country (2018-2023) & (K Units)
Table 124. South America Flu RNA Vaccines Sales Quantity by Country (2024-2029) & (K Units)
Table 125. South America Flu RNA Vaccines Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Flu RNA Vaccines Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Flu RNA Vaccines Sales Quantity by Type (2018-2023) & (K Units)
Table 128. Middle East & Africa Flu RNA Vaccines Sales Quantity by Type (2024-2029) & (K Units)
Table 129. Middle East & Africa Flu RNA Vaccines Sales Quantity by Application (2018-2023) & (K Units)
Table 130. Middle East & Africa Flu RNA Vaccines Sales Quantity by Application (2024-2029) & (K Units)
Table 131. Middle East & Africa Flu RNA Vaccines Sales Quantity by Region (2018-2023) & (K Units)
Table 132. Middle East & Africa Flu RNA Vaccines Sales Quantity by Region (2024-2029) & (K Units)
Table 133. Middle East & Africa Flu RNA Vaccines Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Flu RNA Vaccines Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Flu RNA Vaccines Raw Material
Table 136. Key Manufacturers of Flu RNA Vaccines Raw Materials
Table 137. Flu RNA Vaccines Typical Distributors
Table 138. Flu RNA Vaccines Typical Customers

LIST OF FIGURES

Figure 1. Flu RNA Vaccines Picture
Figure 2. Global Flu RNA Vaccines Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Flu RNA Vaccines Consumption Value Market Share by Type in 2022
Figure 4. Non-Replicating mRNA Examples
Figure 5. In Vivo Self-Replicating mRNA Examples
Figure 6. In Vitro Dendritic Cell Non-Replicating mRNA Vaccine Examples
Figure 7. Others Examples
Figure 8. Global Flu RNA Vaccines Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Flu RNA Vaccines Consumption Value Market Share by Application in 2022
Figure 10. Hospitals Examples
Figure 11. Vaccination Center Examples
Figure 12. Specialized Clinics Examples
Figure 13. Hospital Pharmacy Examples
Figure 14. Others Examples
Figure 15. Global Flu RNA Vaccines Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Flu RNA Vaccines Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Flu RNA Vaccines Sales Quantity (2018-2029) & (K Units)
Figure 18. Global Flu RNA Vaccines Average Price (2018-2029) & (US$/Unit)
Figure 19. Global Flu RNA Vaccines Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Flu RNA Vaccines Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Flu RNA Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Flu RNA Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Flu RNA Vaccines Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Flu RNA Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Flu RNA Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Flu RNA Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Flu RNA Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Flu RNA Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Flu RNA Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Flu RNA Vaccines Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Flu RNA Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Flu RNA Vaccines Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Flu RNA Vaccines Average Price by Type (2018-2029) & (US$/Unit)
Figure 34. Global Flu RNA Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Flu RNA Vaccines Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Flu RNA Vaccines Average Price by Application (2018-2029) & (US$/Unit)
Figure 37. North America Flu RNA Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Flu RNA Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Flu RNA Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Flu RNA Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Flu RNA Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Flu RNA Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Flu RNA Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Flu RNA Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Flu RNA Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Flu RNA Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Flu RNA Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Flu RNA Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 57. China Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Flu RNA Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Flu RNA Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Flu RNA Vaccines Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Flu RNA Vaccines Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Flu RNA Vaccines Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Flu RNA Vaccines Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Flu RNA Vaccines Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Flu RNA Vaccines Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Flu RNA Vaccines Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Flu RNA Vaccines Market Drivers
Figure 78. Flu RNA Vaccines Market Restraints
Figure 79. Flu RNA Vaccines Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Flu RNA Vaccines in 2022
Figure 82. Manufacturing Process Analysis of Flu RNA Vaccines
Figure 83. Flu RNA Vaccines Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source


More Publications